Differin Acne Clearing Body

Description

DIFFERIN® Acne-Clearing Body Spray is formulated with 2% salicylic acid, a maximum strength over-the-counter ingredient designed to effectively eliminate acne bumps, pimples, and blackheads. The formulation includes witch hazel, which provides soothing properties to the skin. This product is delivered in a 360° continuous non-aerosol spray format, ensuring even application. The net weight of the product is 6 ounces (170 grams).

Uses and Indications

This drug is indicated for the management of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Before initiating treatment, it is recommended that a sensitivity test be conducted for new users. This involves applying the product sparingly to one or two small affected areas for the first three days. Prior to application, the skin should be cleaned thoroughly to ensure optimal product efficacy.

For the treatment of the affected area, the product should be applied as a thin layer, covering the entire affected area. The recommended frequency of application is one to three times daily. It is advisable to start with one application per day, gradually increasing to two or three times daily as needed or as directed by a healthcare professional.

In cases where bothersome dryness or peeling occurs, the frequency of application should be reduced to once a day or every other day to mitigate these effects.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to discontinue use and consult a healthcare professional if severe irritation occurs.

Warnings and Precautions

For external use only. This product is not intended for ingestion. In the event of accidental swallowing, it is imperative to seek medical assistance immediately or contact a Poison Control Center.

Healthcare professionals should advise patients to discontinue use and consult a physician if severe irritation occurs. Monitoring for signs of irritation is essential to ensure patient safety and to prevent potential complications.

In cases of ingestion, emergency medical help should be sought without delay. Prompt action is crucial to mitigate any adverse effects associated with swallowing the product.

Side Effects

Patients should be aware that the product is intended for external use only. In the event that irritation becomes severe, it is advised to stop use and consult a healthcare professional.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Differin Acne Clearing Body (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy, including safety concerns, dosage modifications, or special precautions. Therefore, healthcare professionals should exercise caution when prescribing this product to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be informed of the lack of data and encouraged to discuss any concerns with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, the following management procedures should be considered:

1. Assessment: Conduct a thorough assessment of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide supportive care as needed, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Consultation: Engage with a poison control center or a medical toxicologist for guidance on specific interventions and antidotes, if applicable.

4. Documentation: Document all findings, interventions, and the patient's response to treatment meticulously.

Healthcare professionals should remain vigilant and prepared to implement appropriate measures in the event of an overdose, even in the absence of specific guidelines.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is important for patients to understand the potential risks associated with accidental ingestion.

Patients should also be informed to discontinue use and consult a doctor if they experience severe irritation. This guidance is crucial to ensure that any adverse reactions are addressed promptly and appropriately.

Additionally, healthcare providers should caution patients about the increased likelihood of skin irritation and dryness when using this medication concurrently with other topical acne treatments. Patients should be encouraged to use only one topical acne medication at a time to minimize the risk of irritation and to optimize treatment outcomes.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is protected from light exposure. Freezing the product is strictly prohibited, as it may compromise its integrity.

To maintain optimal conditions, the container must be kept tightly closed when not in use. Additionally, it is important to discard the product after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically. For new users, it is recommended to conduct a sensitivity test by applying the product sparingly to one or two small affected areas during the first three days. If no discomfort is experienced, patients should clean the skin thoroughly before applying a thin layer to the entire affected area one to three times daily. To minimize the risk of excessive skin drying, it is advised to start with one application daily, gradually increasing to two or three times daily as needed or directed by a clinician. Should bothersome dryness or peeling occur, patients should reduce the application frequency to once a day or every other day.

Drug Information (PDF)

This file contains official product information for Differin Acne Clearing Body, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)